Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum Toxin Type A for Idiopathic Overactive Bladder
NCT00910845Phase 3Completed
- Sponsor
- Allergan
- Start
- Sep 2009
- Primary completion
- Jul 2011
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 2
01
Overview
A Phase 3 trial of onabotulinumtoxinA in overactive bladder (OAB), sponsored by Allergan. Started Sep 2009; status: completed.
02
Drugs
onabotulinumtoxinA
03
Conditions
overactive bladder (OAB)
Beyond the preview
Go deeper on NCT00910845.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00910845.